Cryo Cell International (CCEL) Cash & Current Investments (2010 - 2026)

Cryo Cell International has disclosed Cash & Current Investments across 17 years of filings, most recently posting $2.9 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 16.65% year-over-year to $2.9 million; the TTM figure through Feb 2026 stood at $2.9 million (down 16.65% YoY), while the FY2025 annual figure was $3.3 million, down 5.72% from the prior year.
• Cash & Current Investments declined to $2.9 million in Q1 2026, from $3.3 million in the prior quarter.
• Over the last five years, Cash & Current Investments for CCEL reached as high as $4.4 million in Q2 2025 and fell as low as $979593.0 in Q1 2024.
• The 5-year median for Cash & Current Investments is $2.6 million (2022), against an average of $2.5 million.
• Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 79.35% — and 2024, when it surged 256.66%.
• A 5-year view of Cash & Current Investments shows it stood at $1.7 million in 2022, then plunged by 43.06% to $980250.0 in 2023, then surged by 256.66% to $3.5 million in 2024, then declined by 5.72% to $3.3 million in 2025, then fell by 12.01% to $2.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $2.9 million, $3.3 million, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.